A network view on Psychiatry

Neurocircuitry: A Window into the Networks Underlying Neuropsychiatric Disease Suzanne N Haber and Scott L Rauch Neuropsychopharmacology 2010 35: 1-3; 10.1038/npp.2009.146 Abstract Full Text The Circuits Top The Reward Circuit: Linking Primate Anatomy and Human Imaging Suzanne N Haber and Brian Knutson Neuropsychopharmacology 2010 35: 4-26; advance online publication, October 7, 2009; 10.1038/npp.2009.129 Abstract Full Text Cortico-Basal Ganglia Reward Network: Microcircuitry Susan R Sesack and Anthony A Grace Neuropsychopharmacology 2010 35: 27-47; advance online publication, August 12, 2009; 10.1038/npp.2009.93 Abstract Full Text Human and Rodent Homologies in Action Control: Corticostriatal Determinants of Goal-Directed and Habitual Action Bernard W Balleine and John P O'Doherty Neuropsychopharmacology 2010 35: 48-69; advance online publication, September 23, 2009; 10.1038/npp.2009.131 Abstract Full Text The Neural Circuitry of Executive Functions in Healthy Subjects and Parkinson's Disease Sandra E Leh, Michael Petrides and Antonio P Strafella Neuropsychopharmacology 2010 35: 70-85; advance online publication, August 5, 2009; 10.1038/npp.2009.88 Abstract Full Text The Episodic Memory System: Neurocircuitry and Disorders Bradford C Dickerson and Howard Eichenbaum Neuropsychopharmacology 2010 35: 86-104; advance online publication, September 23, 2009; 10.1038/npp.2009.126 Abstract Full Text Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety Michael Davis, David L Walker, Leigh Miles and Christian Grillon Neuropsychopharmacology 2010 35: 105-135; advance online publication, August 19, 2009; 10.1038/npp.2009.109 Abstract Full Text Changing Fear: The Neurocircuitry of Emotion Regulation Catherine A Hartley and Elizabeth A Phelps Neuropsychopharmacology 2010 35: 136-146; advance online publication, August 26, 2009; 10.1038/npp.2009.121 Abstract Full Text Normal Development of Brain Circuits Gregory Z Tau and Bradley S Peterson Neuropsychopharmacology 2010 35: 147-168; advance online publication, September 30, 2009; 10.1038/npp.2009.115 Abstract Full Text Circuit Pathophysiology Underlying Disease States Top The Neurocircuitry of Fear, Stress, and Anxiety Disorders Lisa M Shin and Israel Liberzon Neuropsychopharmacology 2010 35: 169-191; advance online publication, July 22, 2009; 10.1038/npp.2009.83 Abstract Full Text Neurocircuitry of Mood Disorders Joseph L Price and Wayne C Drevets Neuropsychopharmacology 2010 35: 192-216; advance online publication, August 19, 2009; 10.1038/npp.2009.104 Abstract Full Text Neurocircuitry of Addiction George F Koob and Nora D Volkow Neuropsychopharmacology 2010 35: 217-238; advance online publication, August 26, 2009; 10.1038/npp.2009.110 Abstract Full Text Amygdalocortical Circuitry in Schizophrenia: From Circuits to Molecules Francine M Benes Neuropsychopharmacology 2010 35: 239-257; advance online publication, September 2, 2009; 10.1038/npp.2009.116 Abstract Full Text Executive Function, Neural Circuitry, and Genetic Mechanisms in Schizophrenia Daniel Paul Eisenberg and Karen Faith Berman Neuropsychopharmacology 2010 35: 258-277; advance online publication, August 19, 2009; 10.1038/npp.2009.111 Abstract Full Text Attention-Deficit/Hyperactivity Disorder and Attention Networks George Bush Neuropsychopharmacology 2010 35: 278-300; advance online publication, September 16, 2009; 10.1038/npp.2009.120 Abstract Full Text Emerging Therapeutic Techniques Top Noninvasive techniques for probing neurocircuitry and treating illness: vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) Mark S George and Gary Aston-Jones Neuropsychopharmacology 2010 35: 301-316; advance online publication, August 19, 2009; 10.1038/npp.2009.87 Abstract Full Text Invasive Circuitry-Based Neurotherapeutics: Stereotactic Ablation and Deep Brain Stimulation for OCD Benjamin D Greenberg, Scott L Rauch and Suzanne N Haber Neuropsychopharmacology 2010 35: 317-336; advance online publication, September 16, 2009; 10.1038/npp.2009.128 Abstract Full Text Hot Topics in Neurocircuitry Top The role of the ventral pallidum in psychiatric disorders T Celeste Napier and Amanda L Mickiewicz Neuropsychopharmacology 2010 35: 337; 10.1038/npp.2009.113 Abstract Full Text Exploring the molecular basis of addiction: drug-induced neuroadaptations Jose A Morón and Thomas A Green Neuropsychopharmacology 2010 35: 337-338; 10.1038/npp.2009.106 Abstract Full Text The emerging role of integrins in neuropsychiatric disorders Ana M D Carneiro Neuropsychopharmacology 2010 35: 338-339; 10.1038/npp.2009.134 Abstract Full Text Imaging advances in developing new medications for addiction Frederick Gerard Moeller, Kimberly L Kjome and Liangsuo Ma Neuropsychopharmacology 2010 35: 339-340; 10.1038/npp.2009.98 Abstract Full Text Sex-related functional asymmetry in the limbic brain Timothy Koscik, Antoine Bechara and Daniel Tranel Neuropsychopharmacology 2010 35: 340-341; 10.1038/npp.2009.122 Abstract Full Text Dissecting the neural circuitry of addiction and psychiatric disease with optogenetics Garret D Stuber Neuropsychopharmacology 2010 35: 341-342; 10.1038/npp.2009.102 Abstract Full Text Neurocartography Narayanan Kasthuri and Jeff W Lichtman Neuropsychopharmacology 2010 35: 342-343; 10.1038/npp.2009.138 Abstract Full Text Modafinil: an anti-relapse medication Pouya Tahsili-Fahadan, Robert Malcolm and Gary Aston-Jones Neuropsychopharmacology 2010 35: 343-344; 10.1038/npp.2009.123 Abstract Full Text Trick or treat? neurodevelopmental consequences of pharmacotherapy for affective disorders Douglas O Frost, Robbin Gibb and Bryan Kolb Neuropsychopharmacology 2010 35: 344-345; 10.1038/npp.2009.133 Abstract Full Text Ligand functional selectivity advances our understanding of drug mechanisms and drug discovery Richard B Mailman and Vishakantha Murthy Neuropsychopharmacology 2010 35: 345-346; 10.1038/npp.2009.117 Abstract Full Text Induced pluripotent stem (iPS) cells and their future in psychiatry Kwang-Soo Kim Neuropsychopharmacology 2010 35: 346-348; 10.1038/npp.2009.108 Abstract Full Text Advances in PET analyses of stress and dopamine Romina Mizrahi Neuropsychopharmacology 2010 35: 348-349; 10.1038/npp.2009.132 Abstract Full Text Imaging and genetics advances in understanding geriatric depression David C Steffens Neuropsychopharmacology 2010 35: 349-350; 10.1038/npp.2009.135 Abstract Full Text Neuronal signaling pathways: genetic insights into the pathophysiology of major mental illness Russell L Margolis and Christopher A Ross Neuropsychopharmacology 2010 35: 350-351; 10.1038/npp.2009.137 Abstract Full Text Antidepressants, age, and neuroprogenitors Maura Boldrini and Victoria Arango Neuropsychopharmacology 2010 35: 351-352; 10.1038/npp.2009.130 Abstract Full Text Normalizing drug-induced neuronal plasticity in nucleus accumbens weakens enduring drug-seeking behavior Wenhua Zhou Neuropsychopharmacology 2010 35: 352-353; 10.1038/npp.2009.97 Abstract Full Text Orexin/hypocretin in psychiatric disorders: present state of knowledge and future potential Stephanie L Borgland and Gwenaël Labouèbe Neuropsychopharmacology 2010 35: 353-354; 10.1038/npp.2009.119 Abstract Full Text New vaccine development for chronic brain disease Alan DT Barrett, Rakez Kayed, George R Jackson and Kathryn A Cunningham Neuropsychopharmacology 2010 35: 354; 10.1038/npp.2009.147 Abstract Full Text Convergent Functional Genomics: what we have learned and can learn about genes, pathways, and mechanisms Alexander B Niculescu and Helen Le-Niculescu Neuropsychopharmacology 2010 35: 355-356; 10.1038/npp.2009.107 Abstract Full Text